-
meps.ahrq.gov/data_files/publications/rf41/rf41.shtml
May 01, 2019 - older
Two preventive services, cervical cancer screening for women and prostate-specific antigen (PSA … screening, and one-half (50.2 percent) of eligible men age 75 and older correctly did not receive PSA … age 75 and older
Women Age 75+
Did not have a hysterectomy or ever have cervical cancer
PSA … Did not have prostate specific antigen test (PSA) since age 75 and older
Men Age 75+
Did not … not be received after age 75
Cervical cancer screening
XN
PSA
-
www.ahrq.gov/research/findings/studies/index.html?page=184
January 01, 2024 - Safety and Quality, Imaging
Chapman CH , Caram MEV , Radhakrishnan A Association between PSA … This study examined the association between PSA values and posttreatment surveillance after prostate … Association between PSA values and surveillance quality after prostate cancer surgery.
-
pbrn.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/research-centers/vu_physician_patient_harms.pdf
September 18, 2014 - Clinicians could name harms of screening for prostate cancer using the Prostate Specific Antigen test
(PSA
-
pcmh.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/research-centers/vu_physician_patient_harms.pdf
September 18, 2014 - Clinicians could name harms of screening for prostate cancer using the Prostate Specific Antigen test
(PSA
-
patientregistry.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/research-centers/vu_physician_patient_harms.pdf
September 18, 2014 - Clinicians could name harms of screening for prostate cancer using the Prostate Specific Antigen test
(PSA
-
talkingquality.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/research-centers/vu_physician_patient_harms.pdf
September 18, 2014 - Clinicians could name harms of screening for prostate cancer using the Prostate Specific Antigen test
(PSA
-
cahps.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/research-centers/vu_physician_patient_harms.pdf
September 18, 2014 - Clinicians could name harms of screening for prostate cancer using the Prostate Specific Antigen test
(PSA
-
healthcare411.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/research-centers/vu_physician_patient_harms.pdf
September 18, 2014 - Clinicians could name harms of screening for prostate cancer using the Prostate Specific Antigen test
(PSA
-
monahrq.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/research-centers/vu_physician_patient_harms.pdf
September 18, 2014 - Clinicians could name harms of screening for prostate cancer using the Prostate Specific Antigen test
(PSA
-
ahrqpubs.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/research-centers/vu_physician_patient_harms.pdf
September 18, 2014 - Clinicians could name harms of screening for prostate cancer using the Prostate Specific Antigen test
(PSA
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/research-centers/vu_physician_patient_harms.pdf
September 18, 2014 - Clinicians could name harms of screening for prostate cancer using the Prostate Specific Antigen test
(PSA
-
meps.ahrq.gov/data_files/publications/rf41/rf41.pdf
May 01, 2019 - older
Two preventive services, cervical cancer screening for women and prostate-specific antigen (PSA … screening, and one-half (50.2 percent) of eligible
men age 75 and older correctly did not receive PSA … since age 75 and
older
Women
Age 75+
Did not have a hysterectomy
or ever have cervical cancer
PSA … Did not have prostate specific antigen
test (PSA) since age 75 and older
Men
Age 75+
Did not have … screening X X
Services that should not be received after age 75
Cervical cancer screening XN
PSA
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol1/Advances-Browne_5.pdf
January 20, 2008 - Available at:
www.psa.state.pa.us/psa/lib/psa/act_13/act_13.pdf.
Accessed January 10, 2008.
9. … NR/rdonlyres/F84F9DC6-A5DA-490F-A91F-A9FCE26347C4/0/SE_chapter_july07.pdf
http://www.psa.state.pa.us/psa … /lib/psa/act_13/act_13.pdf
14.
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-230-prostate-cancer-comments.pdf
September 17, 2020 - • The reviewers repeatedly emphasized the distinction between mostly PSA-based
active monitoring
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-230-prostate-cancer-comments.pdf
September 17, 2020 - • The reviewers repeatedly emphasized the distinction between mostly PSA-based
active monitoring
-
psnet.ahrq.gov/web-mm/hold-order
December 19, 2018 - Available at: http://www.psa.state.pa.us/psa/lib/psa/advisories/mar_2006_advisory_v3_n1.pdf . 2.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
November 02, 2019 - , or ablated.3, 4 Instead, tumors are monitored through
surveillance of prostate specific antigen (PSA … patient characteristics (e.g., age, ethnicity, comorbidities, preferences),
tumor characteristics (e.g., PSA … 1) Baseline PSA
2) Gleason score
3) Tumor index scores (e.g., Cancer of the Prostate Risk Assessment … hormone-releasing hormone
MRI= magnetic resonance imaging
NCCN= National Comprehensive Cancer Network
PSA
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
November 02, 2019 - , or ablated.3, 4 Instead, tumors are monitored through
surveillance of prostate specific antigen (PSA … patient characteristics (e.g., age, ethnicity, comorbidities, preferences),
tumor characteristics (e.g., PSA … 1) Baseline PSA
2) Gleason score
3) Tumor index scores (e.g., Cancer of the Prostate Risk Assessment … hormone-releasing hormone
MRI= magnetic resonance imaging
NCCN= National Comprehensive Cancer Network
PSA
-
effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-therapies/protocol
March 01, 2020 - or ablated. 3 , 4 Instead, tumors are monitored through surveillance of prostate specific antigen (PSA … patient characteristics (e.g., age, ethnicity, comorbidities, preferences), tumor characteristics (e.g., PSA … Baseline PSA
Gleason score
Tumor index scores (e.g., Cancer of the Prostate Risk Assessment Score … hormone-releasing hormone
MRI= magnetic resonance imaging
NCCN= National Comprehensive Cancer Network
PSA
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol1/Advances-Clarke_8.pdf
January 25, 2008 - Available at:
www.psa.state.pa.us/psa/lib/psa/act_13/act_13.pdf.
Accessed January 25, 2008.
4. … Sudbury MA: Jones &
Bartlett; 2004. p. 169-186.
13
http://www.psa.state.pa.us/psa/lib/psa/act_13